[go: up one dir, main page]

WO2018024145A1 - Process for preparing boscalid - Google Patents

Process for preparing boscalid Download PDF

Info

Publication number
WO2018024145A1
WO2018024145A1 PCT/CN2017/094624 CN2017094624W WO2018024145A1 WO 2018024145 A1 WO2018024145 A1 WO 2018024145A1 CN 2017094624 W CN2017094624 W CN 2017094624W WO 2018024145 A1 WO2018024145 A1 WO 2018024145A1
Authority
WO
WIPO (PCT)
Prior art keywords
boscalid
process according
elevated temperature
solution
anhydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2017/094624
Other languages
French (fr)
Inventor
James Timothy BRISTOW
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Rotam Chemical Co Ltd
Original Assignee
Jiangsu Rotam Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Rotam Chemical Co Ltd filed Critical Jiangsu Rotam Chemical Co Ltd
Priority to CN201780044954.4A priority Critical patent/CN109476603A/en
Publication of WO2018024145A1 publication Critical patent/WO2018024145A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Definitions

  • the present invention relates to a process for preparing boscalid, in particular to a process for preparing a specific crystalline form of boscalid.
  • Boscalid is a fungicide of the carboxamide group and acts as a succinate dehydrogenase inhibitor (SDHI) , a respiratory inhibitor of mitochondria.
  • SDHI succinate dehydrogenase inhibitor
  • Boscalid is active as a fungicide and is now commercially available in a range of formulations for the treatment of fungal infestations and the resulting disorders.
  • US 7,087,239 concerns the crystalline hydrates of either nicotinic acid anilide and/or benzoyl anilide derivatives.
  • the synthesis and recovery of the hydrate of boscalid is specifically exemplified in US 7,087,239.
  • the hydrate is obtained by first preparing the anhydrate of boscalid, which is obtained at the end of the synthesis procedure as a solution in hot xylene. Upon cooling, boscalid crystallized from the solution and was dried under vacuum in an oven.
  • the anhydrate is indicated to have the following physical properties:
  • US 7,087,239 discloses that the hydrate can be formed by dissolving the anhydrate in tetrahydrofuran (THF) at 40°C in a solvent and adding the resulting solution into water. The precipitate was isolated from the resulting mixture by filtration and dried, to yield the monohydrate of boscalid.
  • THF tetrahydrofuran
  • the crystalline modification of the anhydrate of boscalid disclosed in US 7,087,239 is referred to herein as the crystalline modification I of boscalid.
  • boscalid is synthesized by the reaction of 2-chloro-3-nicotinyl chloride II with 2- (4-chlorophenyl) aniline in a solvent system, in particular xylene. Boscalid was crystallized by steady cooling of the organic solution, after extraction with sodium carbonate solution.
  • US 7,501,384 discloses an alleged novel crystalline modification of the anhydrate of boscalid.
  • the crystalline modification disclosed in US 7,501,384 is referred to herein as the crystalline modification II of boscalid. It is suggested in US 7,501,384 that the crystalline modification II of boscalid is more suitable for making various formulations, which otherwise require prolonged grinding/milling processes.
  • a, b, c edge lengths of the unit cell
  • Z number of molecules in the unit cell.
  • the present invention provides a process for preparing the crystalline modification II of the anhydrate of boscalid, the process comprising providing a solution of boscalid in an organic solvent system, heating the solution to an elevated temperature, and precipitating solid boscalid from the solution, the elevated temperature being sufficient to preferentially form the crystalline modification II of the anhydrate of boscalid.
  • an elevated temperature is used to form the crystalline modification II of the anhydrate of boscalid.
  • elevated temperatures result in the crystalline modification II of the anhydrate of boscalid being preferentially formed, compared with lower temperatures.
  • the process of the present invention employs a boscalid starting material.
  • the boscalid starting material is a solution of boscalid in an organic solvent system. Any suitable organic solvent system for boscalid may be used to form the boscalid starting material of this embodiment.
  • the solvent system may be a single organic solvent or a mixture of two or more solvents.
  • Suitable solvents include polar organic solvents and aromatic hydrocarbons.
  • Preferred polar organic solvents are alcohols, including polyols, such as glycols, ketones, ethers, esters, amides and mixtures thereof.
  • suitable alcohols are C 1 to C 8 alcohols, preferably C 1 to C 5 alcohols.
  • the alcohol may be a straight chain or branched aliphatic alcohol, more preferably ethanol, propanol and butanol.
  • the alcohol may be an alicyclic alcohol, for example cyclohexanol.
  • the solvent may comprise a polyol, such as a glycol.
  • suitable glycols are mono-and polyethylene glycols, preferably ethylene glycol and diethylene glycol.
  • ketones examples include C 3 to C 8 ketones, preferably C 3 to C 6 ketones, more preferably propanone, butanone, pentanone and hexanone.
  • the ketones may be straight chain, branched chain or cyclic, for example alkyl propanones and cyclohexanone.
  • Suitable ethers are C 3 to C 8 ethers, preferably C 3 to C 6 ethers.
  • the ethers may be straight chain, branched chain or cyclic, for example dioxane and tetrahydrofuran.
  • esters are C 3 to C 8 esters, preferably C 3 to C 6 esters, more preferably ethyl acetate and methyl acetate.
  • Suitable amides are C 3 to C 8 amides, preferably C 3 to C 6 amides, more preferably dimethylformamide.
  • Suitable aromatic solvents are benzene, toluene and xylene.
  • Xylene is one preferred solvent.
  • Suitable solvents are known in the art and are commercially available.
  • the organic solvent may comprise a combination of an aromatic solvent, such as benzene, xylene or toluene, or a cyclic alkane, such as cyclohexene, with one or more aliphatic or alicyclic alcohols, such as cyclohexanol, one or more ketones, one or more ethers, such as a cyclic ether, for example tetrahydrofuran, or one or more amides.
  • an aromatic solvent such as benzene, xylene or toluene
  • a cyclic alkane such as cyclohexene
  • alcohols such as cyclohexanol
  • ketones such as cyclohexanol
  • ethers such as a cyclic ether, for example tetrahydrofuran, or one or more amides.
  • the organic solvent employed in the process of the present invention is preferably substantially free from water, to ensure the maximum yield of the anhydrate of boscalid.
  • the organic solvent may comprise up to 0.4%by weight of water, which may be absorbed by the solvent from the atmosphere. Most preferably, the organic solvent contains no water.
  • the solution of boscalid may be formed in any suitable manner.
  • the solution may be formed by dissolving a form of boscalid other than solid crystalline modification II of boscalid in the organic solvent system.
  • boscalid may be synthesized in the presence of the organic solvent. Suitable methods for synthesizing boscalid in solution in an organic solvent are known in the art.
  • US 7,087,239 discloses a suitable synthesis route for preparing boscalid.
  • the process of the present invention comprises precipitating solid boscalid from the solution of boscalid in the organic solvent.
  • the solution is heated to an elevated temperature.
  • the elevated temperature is above ambient temperature or room temperature and is a temperature at which the precipitation preferentially yields the crystalline modification II of the anhydrate of boscalid. Any suitable elevated temperature may be employed.
  • the elevated temperature is below the boiling point of the solution of boscalid.
  • Suitable elevated temperatures may be determined by analysis of the precipitated boscalid material, in particular to determine whether the temperature is sufficiently high for the modification II of the anhydrate of boscalid to be precipitated.
  • the elevated temperature is preferably at least 35°C, more preferably at least 40°C, still more preferably at least 45°C.
  • the boscalid is precipitated from the solution after heating to a temperature of at least 50°C, still more preferably at least 55°C, more preferably still at least 60°C.
  • precipitation of solid boscalid from solution in an organic solvent after heating to a temperature of 65°C results in the formation of 100%by weight of the crystalline modification II of the anhydrate of boscalid.
  • the elevated temperature is preferably below the boiling point of the organic solvents and the solution of the boscalid starting material.
  • the elevated temperature is also below the melting point of the crystalline modification II of the anhydrate of boscalid.
  • the upper limit of the elevated temperature will depend upon the particular solvent or solvent system employed.
  • the elevated temperature is preferably below 140°C, more preferably below 130°C, still more preferably below 120°C, more preferably still below 110°C.
  • the solid boscalid starting material is heated to an elevated temperature below 100°C, more preferably below 90°C, still more preferably below 85°C, more preferably still below 80°C.
  • Elevated temperatures in the range of from 30 to 130°C are preferably employed, more preferably from 35 to 120°C, still more preferably from 40 to 110°C, more preferably still from 45 to 100°C, with temperatures in the range of from 50 to 90°C being preferred, more preferably from 55 to 85°C, still more preferably from 60 to 80°C.
  • a temperature of from 60 to 70°C is particularly preferred, with a temperature of about 65°C resulting in the formation of substantially 100%by weight of the modification II of the anhydrate of boscalid.
  • the precipitation of the boscalid material from the organic solvent may be effected using any suitable technique.
  • the precipitation of boscalid from the solution may be carried out at the elevated temperature.
  • precipitation may be effected by removing the organic solvent at the elevated temperature, for example by evaporation, such as under reduced pressure.
  • precipitation of boscalid from the solution may be carried out at a temperature below the elevated temperature, after heating the solution to the elevated temperature.
  • precipitation of the boscalid material from the organic solvent may be effected by cooling a saturated solution of boscalid in the solvent from the elevated temperature to a lower temperature at which precipitation of solid boscalid occurs.
  • the process may employ a combination of the aforementioned techniques, that is precipitation of the solid boscalid material may be commenced at the elevated temperature and the solution thereafter cooled, for example to allow further solid to precipitate.
  • Cooling may be carried out continuously, stepwise, or a combination thereof.
  • Precipitation of the boscalid product may be carried out in the presence of seed crystals of boscalid, preferably seed crystals of the crystalline modification II of the anhydrate of boscalid in the organic solvent.
  • the process of the present invention may be carried out batchwise or in a continuous manner.
  • Any suitable apparatus may be employed to carry out the precipitation of the crystalline modification II of boscalid. Suitable apparatus is known in the art and is commercially available.
  • the present invention provides a fungicidal formulation comprising the crystalline modification II of the anhydrate of boscalid prepared by a process as described above.
  • FTIR spectrometry may be used to record IR spectra.
  • Figure 1 is the IR spectrum of the crystalline modification II of the anhydrate of boscalid
  • Figure 2 is the IR spectrum of the crystalline modification I of the anhydrate of boscalid.
  • Boscalid was prepared according to the following general reaction scheme:
  • a reaction vessel was charged with 396g (1.944 mol) of 2-amino-4'-chlorobiphenyl in 311g of xylene and the mixture was stirred until a homogenous solution was obtained.
  • a solution of 349g (1.984 mol) of 2-chloro-3-nicotinyl chloride in 233g of xylene was added to the reaction vessel and the resultant mixture allowed to heat up to 30°C.
  • the resultant mixture was heated to an elevated temperature of 95°C over a period of 4 to 5 hours.
  • Hydrogen chloride (HCl) produced by the reactions was removed using an external scrubber and absorption by a spray tower using water and an alkali solution.
  • the reaction mixture was further maintained for a period of 30 minutes with stirring at the same elevated temperature to remove all traces of all HCL. Thereafter, the reaction mixture was allowed to cool to 30°C during the period of 5 to 7 hours with slow stirring.
  • the boscalid material recovered was analyzed using infrared (IR) spectrometry using a Bruker model No. Tensor 37 spectrometer, with a recording wavelength of 550 to 4000 cm -1 , having 16 scans with a highest resolution of 4 cm -1 .
  • IR infrared
  • the analysis showed the solid product to be the crystalline modification II of the anhydrate of boscalid.
  • the cooled mixture was diluted with 500g of toulene and 200g of triethyl amine (TEA) with stirring.
  • TEA triethyl amine
  • 400g of 4’-chlorobiphenyl-2-amine was added over a period of 30 to 45 minutes at 45°C and the mixture stirred for an additional 4 to 5 hours to allow the reaction to complete.
  • the mixture was quenched by adding water and stirring for a further 2 to 3 hours.
  • the organic layer was separated and maintained at an elevated temperature of 60°C.
  • the mixture was filtered to remove insoluble impurities.
  • the mixture was finally cooled to 10 to 15°C under slow stirring.
  • the solid was isolated by filtration and drying to give 450 to 480g of boscalid.
  • Example 2 The solid was analysed by IR spectroscopy, as in Example 1, which showed the solid product to be the crystalline modification II of the anhydrate of boscalid.
  • a reaction vessel was charged with 792g (3.888 mol) of 2-amino-4'-chlorobiphenyl in 622g of xylene and the mixture was stirred until a homogenous solution was obtained.
  • a solution of 698g (3.968 mol) of 2-chloro-3-nicotinyl chloride in 466g of xylene was added to the reaction vessel and the resultant mixture allowed to heat up to a temperature of 30°C.
  • the resultant mixture was heated to an elevated temperature of 95°C over a period of 4 to 5 hours.
  • Hydrogen chloride (HCl) produced by the reactions was removed using an external scrubber and absorption by a spray tower using water and an alkali solution.
  • the reaction mixture was further maintained for a period of from 2 to 3 hours with stirring at the same elevated temperature to remove all traces of all HCl.
  • the resulting mixture was seeded with seed crystals of the crystalline modification II of the anhydrate of boscalid, resulting in the precipitation of a solid material, which was collected by filtration. Traces of xylene were removed from the precipitate by vacuum drying in an oven.
  • the solid material collected was analyzed using infrared (IR) spectrometry using a Bruker model No. Tensor 37 spectrometer, with a recording wavelength of 550 to 4000 cm -1 , having 16 scans with a highest resolution of 4 cm -1 .
  • the analysis showed the solid product to be the crystalline modification II of the anhydrate of boscalid.
  • the resulting mixture was cooled to obtain a solid precipitate.
  • the solid was isolated by filtration and drying.
  • Example 2 The solid was analysed by IR spectroscopy, as in Example 1, which showed the solid product to be the crystalline modification II of the anhydrate of boscalid.
  • Example 1 To investigate the effects of temperature on the solid boscalid material obtained in the process, the procedure of Example 1 was repeated with precipitating solid boscalid from the xylene solution held at a range of different elevated temperatures before cooling.
  • the form of the boscalid anhydrate precipitated from the organic solvent is dependent upon the temperature of the solution of boscalid from which the precipitation is carried out.
  • precipitation from xylene heated to a temperature of 65°C yielded 100%of the crystalline modification II of the anhydrate of boscalid.
  • precipitation from the xylenic solution heated to just 30°C yielded only 10 to 20%of the crystalline modification II of the anhydrate of boscalid, with predominantly crystalline modification I of boscalid being formed at this temperature.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for preparing the crystalline modification II of the anhydrate of boscalid is provided, the process comprising providing a solution of boscalid in an organic solvent system, heating the solution to an elevated temperature, and precipitating solid boscalid from the solution, the elevated temperature being sufficient to preferentially form the crystalline modification II of the anhydrate of boscalid.

Description

PROCESS FOR PREPARING BOSCALID
CROSS-REFERENCE TO RELATED APPLICATION
This application claims priority to GB Patent Application No. 1613462.9, titled “PROCESS FOR PREPARING BOSCALID” , filed with GB Intellectual Property Office on August 4, 2016, the entire contents of which are incorporated herein by reference.
FIELD
The present invention relates to a process for preparing boscalid, in particular to a process for preparing a specific crystalline form of boscalid.
BACKGROUND
The compound 2-chloro-N- (4’chloro [1, 1’biphenyl] -2-yl) -3-pyridine carboxamide, having the common name boscalid, has the structural formula I:
Figure PCTCN2017094624-appb-000001
Boscalid is a fungicide of the carboxamide group and acts as a succinate dehydrogenase inhibitor (SDHI) , a respiratory inhibitor of mitochondria. This class of carboximide compounds and the activity of the compounds was first described in US 4,001,416 and US 5,330,995.
Boscalid is active as a fungicide and is now commercially available in a range of formulations for the treatment of fungal infestations and the resulting disorders.
US 7,087,239 concerns the crystalline hydrates of either nicotinic acid anilide and/or benzoyl anilide derivatives. The synthesis and recovery of the hydrate of boscalid is  specifically exemplified in US 7,087,239. The hydrate is obtained by first preparing the anhydrate of boscalid, which is obtained at the end of the synthesis procedure as a solution in hot xylene. Upon cooling, boscalid crystallized from the solution and was dried under vacuum in an oven. The anhydrate is indicated to have the following physical properties:
Figure PCTCN2017094624-appb-000002
US 7,087,239 discloses that the hydrate can be formed by dissolving the anhydrate in tetrahydrofuran (THF) at 40℃ in a solvent and adding the resulting solution into water. The precipitate was isolated from the resulting mixture by filtration and dried, to yield the monohydrate of boscalid. The crystalline modification of the anhydrate of boscalid disclosed in US 7,087,239 is referred to herein as the crystalline modification I of boscalid.
US 7,241,896 concerns a process for producing 2-halogen-pyridine-carboxylic acid amides. The preparation of boscalid is disclosed and exemplified. In the examples, boscalid is synthesized by the reaction of 2-chloro-3-nicotinyl chloride II with 2- (4-chlorophenyl) aniline in a solvent system, in particular xylene. Boscalid was crystallized by steady cooling of the organic solution, after extraction with sodium carbonate solution.
We have found that it is hard to mill the crystalline modification of the anhydrate of boscalid disclosed in US 7,087,239 in water. As a consequence, it is not a straightforward task to directly formulate the crystalline modification of boscalid into desired formulations which require grinding and/or milling processes. Such formulations are, for example, granules, encapsulated granules, tablets, water-dispersible granules, water-dispersible tablets, water-dispersible powders or water dispersible powders for seed treatment, dust formulations, and formulations in which the active compound is present in dispersed form, such as, for example, suspension concentrates, oil-based suspension concentrates, suspoemulsions, or suspension concentrates for seed treatment. Hydration of the crystalline modification of  boscalid is needed prior to formulating into a suspension concentrate.
US 7,501,384 discloses an alleged novel crystalline modification of the anhydrate of boscalid. The crystalline modification disclosed in US 7,501,384 is referred to herein as the crystalline modification II of boscalid. It is suggested in US 7,501,384 that the crystalline modification II of boscalid is more suitable for making various formulations, which otherwise require prolonged grinding/milling processes.
US 7,501,384 describes that the crystalline modification II of boscalid may be prepared by a process comprising:
a) dissolving the anhydrate of the crystalline modification I of boscalid in a polar organic solvent or an aromatic hydrocarbon; and
b) precipitation of the anhydrate of the crystalline modification II of boscalid by cooling the solvent.
An alternative process for the preparation of the crystalline modification II of boscalid disclosed in US 7,501,384 comprises:
a) heating the crystalline modification I of boscalid to above 150℃ until melted; and
b) cooling the melt with the addition of seed crystals of the crystalline modification II of boscalid.
US 7,501,384 describes the crystalline modification II of boscalid as having the following properties:
Figure PCTCN2017094624-appb-000003
The key parameters and the cell matrix obtained from the crystallographic investigations of the crystalline modification II of boscalid using a single crystal diffractometer from Siemens are given in US 7,501,384 as follows:
Figure PCTCN2017094624-appb-000004
Figure PCTCN2017094624-appb-000005
The parameters indicated above have the following meanings:
a, b, c = edge lengths of the unit cell;
α, β, γ = corresponding angles; and
Z = number of molecules in the unit cell.
It would be of significant advantage if an improved process for the preparation of the crystalline modification II of the anhydrate of boscalid could be provided, in particular a process that is suitable for applying on a commercial scale, with reproducible, high yields of the modification II product. Preferably, the process would be simple to operate and easy to control.
Surprisingly, it has now been found that the formation of crystalline modification II of the anhydrate of boscalid in high yields occurs at elevated temperatures. In contrast, lower temperatures result in the crystalline modification I of the anhydrate of boscalid being preferentially formed. In particular, when precipitating boscalid from a solvent system, surprisingly it has been found that precipitation of boscalid from the solvent system at low temperatures yields predominantly or exclusively the crystalline modification I of the anhydrate of boscalid, while increasing the temperature of the solvent system and precipitating solid boscalid preferentially yields the crystalline II modification of the  anhydrate of boscalid.
SUMMARY
In a first aspect, the present invention provides a process for preparing the crystalline modification II of the anhydrate of boscalid, the process comprising providing a solution of boscalid in an organic solvent system, heating the solution to an elevated temperature, and precipitating solid boscalid from the solution, the elevated temperature being sufficient to preferentially form the crystalline modification II of the anhydrate of boscalid.
In the present invention, an elevated temperature is used to form the crystalline modification II of the anhydrate of boscalid. As noted above, such elevated temperatures result in the crystalline modification II of the anhydrate of boscalid being preferentially formed, compared with lower temperatures.
The process of the present invention employs a boscalid starting material. The boscalid starting material is a solution of boscalid in an organic solvent system. Any suitable organic solvent system for boscalid may be used to form the boscalid starting material of this embodiment. The solvent system may be a single organic solvent or a mixture of two or more solvents. Suitable solvents include polar organic solvents and aromatic hydrocarbons. Preferred polar organic solvents are alcohols, including polyols, such as glycols, ketones, ethers, esters, amides and mixtures thereof.
Examples of suitable alcohols are C1 to C8 alcohols, preferably C1 to C5 alcohols. The alcohol may be a straight chain or branched aliphatic alcohol, more preferably ethanol, propanol and butanol. The alcohol may be an alicyclic alcohol, for example cyclohexanol. The solvent may comprise a polyol, such as a glycol. Examples of suitable glycols are mono-and polyethylene glycols, preferably ethylene glycol and diethylene glycol.
Examples of suitable ketones are C3 to C8 ketones, preferably C3 to C6 ketones, more preferably propanone, butanone, pentanone and hexanone. The ketones may be straight chain, branched chain or cyclic, for example alkyl propanones and cyclohexanone.
Examples of suitable ethers are C3 to C8 ethers, preferably C3 to C6 ethers. The ethers may be straight chain, branched chain or cyclic, for example dioxane and tetrahydrofuran.
Examples of suitable esters are C3 to C8 esters, preferably C3 to C6 esters, more preferably ethyl acetate and methyl acetate.
Examples of suitable amides are C3 to C8 amides, preferably C3 to C6 amides, more preferably dimethylformamide.
Suitable aromatic solvents are benzene, toluene and xylene. Xylene is one preferred solvent.
Suitable solvents are known in the art and are commercially available.
A mixture of solvents may be employed as the solvent system. For example, the organic solvent may comprise a combination of an aromatic solvent, such as benzene, xylene or toluene, or a cyclic alkane, such as cyclohexene, with one or more aliphatic or alicyclic alcohols, such as cyclohexanol, one or more ketones, one or more ethers, such as a cyclic ether, for example tetrahydrofuran, or one or more amides.
The organic solvent employed in the process of the present invention is preferably substantially free from water, to ensure the maximum yield of the anhydrate of boscalid. The organic solvent may comprise up to 0.4%by weight of water, which may be absorbed by the solvent from the atmosphere. Most preferably, the organic solvent contains no water.
The solution of boscalid may be formed in any suitable manner. For example, the solution may be formed by dissolving a form of boscalid other than solid crystalline modification II of boscalid in the organic solvent system. Alternatively, boscalid may be synthesized in the presence of the organic solvent. Suitable methods for synthesizing boscalid in solution in an organic solvent are known in the art. US 7,087,239 discloses a suitable synthesis route for preparing boscalid.
The process of the present invention comprises precipitating solid boscalid from the solution of boscalid in the organic solvent. The solution is heated to an elevated temperature. The elevated temperature is above ambient temperature or room temperature and is a temperature at which the precipitation preferentially yields the crystalline modification II of the anhydrate of boscalid. Any suitable elevated temperature may be employed. Preferably, the elevated temperature is below the boiling point of the solution of boscalid.
Suitable elevated temperatures may be determined by analysis of the precipitated boscalid material, in particular to determine whether the temperature is sufficiently high for  the modification II of the anhydrate of boscalid to be precipitated.
The elevated temperature is preferably at least 35℃, more preferably at least 40℃, still more preferably at least 45℃. In experiments, it has been found that the precipitation of boscalid from solution in an organic solvent after heating to a temperature of 45℃ results in a solid boscalid material comprising the crystalline modification II in an amount of 30%by weight.
More preferably, the boscalid is precipitated from the solution after heating to a temperature of at least 50℃, still more preferably at least 55℃, more preferably still at least 60℃. In experiments, it has been found that precipitation of solid boscalid from solution in an organic solvent after heating to a temperature of 65℃ results in the formation of 100%by weight of the crystalline modification II of the anhydrate of boscalid.
As noted above, the elevated temperature is preferably below the boiling point of the organic solvents and the solution of the boscalid starting material. The elevated temperature is also below the melting point of the crystalline modification II of the anhydrate of boscalid.
The upper limit of the elevated temperature will depend upon the particular solvent or solvent system employed. The elevated temperature is preferably below 140℃, more preferably below 130℃, still more preferably below 120℃, more preferably still below 110℃. In preferred embodiments, the solid boscalid starting material is heated to an elevated temperature below 100℃, more preferably below 90℃, still more preferably below 85℃, more preferably still below 80℃.
Elevated temperatures in the range of from 30 to 130℃ are preferably employed, more preferably from 35 to 120℃, still more preferably from 40 to 110℃, more preferably still from 45 to 100℃, with temperatures in the range of from 50 to 90℃ being preferred, more preferably from 55 to 85℃, still more preferably from 60 to 80℃. A temperature of from 60 to 70℃ is particularly preferred, with a temperature of about 65℃ resulting in the formation of substantially 100%by weight of the modification II of the anhydrate of boscalid.
The precipitation of the boscalid material from the organic solvent may be effected using any suitable technique. The precipitation of boscalid from the solution may be carried out at the elevated temperature. For example, precipitation may be effected by removing the organic solvent at the elevated temperature, for example by evaporation, such as under  reduced pressure.
Alternatively, precipitation of boscalid from the solution may be carried out at a temperature below the elevated temperature, after heating the solution to the elevated temperature. In particular, precipitation of the boscalid material from the organic solvent may be effected by cooling a saturated solution of boscalid in the solvent from the elevated temperature to a lower temperature at which precipitation of solid boscalid occurs.
As a further alternative, the process may employ a combination of the aforementioned techniques, that is precipitation of the solid boscalid material may be commenced at the elevated temperature and the solution thereafter cooled, for example to allow further solid to precipitate.
Cooling may be carried out continuously, stepwise, or a combination thereof.
Precipitation of the boscalid product may be carried out in the presence of seed crystals of boscalid, preferably seed crystals of the crystalline modification II of the anhydrate of boscalid in the organic solvent.
The process of the present invention may be carried out batchwise or in a continuous manner.
Any suitable apparatus may be employed to carry out the precipitation of the crystalline modification II of boscalid. Suitable apparatus is known in the art and is commercially available.
In a further aspect, the present invention provides a fungicidal formulation comprising the crystalline modification II of the anhydrate of boscalid prepared by a process as described above.
BRIEF DESCRIPTION OF THE DRAWINGS
FTIR spectrometry may be used to record IR spectra.
Figure 1 is the IR spectrum of the crystalline modification II of the anhydrate of boscalid;
Figure 2 is the IR spectrum of the crystalline modification I of the anhydrate of boscalid.
DETAILED DESCRIPTION OF EMBODIMENTS
Embodiments of the present invention will be described, for illustrative purposes only, by way of the following specific examples.
In the following examples, percentages are weight percent, unless otherwise indicated.
EXAMPLES
Example 1
Boscalid was prepared according to the following general reaction scheme:
Figure PCTCN2017094624-appb-000006
A solution of boscalid in xylene was prepared as follows:
A reaction vessel was charged with 396g (1.944 mol) of 2-amino-4'-chlorobiphenyl in 311g of xylene and the mixture was stirred until a homogenous solution was obtained. A solution of 349g (1.984 mol) of 2-chloro-3-nicotinyl chloride in 233g of xylene was added to the reaction vessel and the resultant mixture allowed to heat up to 30℃.
The resultant mixture was heated to an elevated temperature of 95℃ over a period of 4 to 5 hours. Hydrogen chloride (HCl) produced by the reactions was removed using an external scrubber and absorption by a spray tower using water and an alkali solution. The reaction mixture was further maintained for a period of 30 minutes with stirring at the same elevated temperature to remove all traces of all HCL. Thereafter, the reaction mixture was allowed to cool to 30℃ during the period of 5 to 7 hours with slow stirring.
Finally the solution was cooled to room temperature, resulting in the precipitation of  a solid boscalid material, which was removed by filtration. Traces of xylene were removed from the precipitate by vacuum drying in an oven.
The boscalid material recovered was analyzed using infrared (IR) spectrometry using a Bruker model No. Tensor 37 spectrometer, with a recording wavelength of 550 to 4000 cm-1, having 16 scans with a highest resolution of 4 cm-1. The analysis showed the solid product to be the crystalline modification II of the anhydrate of boscalid.
Example 2
750g of toluene were charged to a reaction vessel under a nitrogen atmosphere. 335g of 2-chloronicotinic acid were added with stirring at room temperature. 35g of dimethyl formamide (DMF) was added to the mixture and the resulting reaction mixture slowly heated to 40℃ with stirring. 300g of thionyl chloride was added over a period of one hour. Hydrogen chloride (HCl) and sulphur dioxide (SO2) gases liberated by the reaction were removed by scrubbing. Thereafter, the reaction mass was kept under a nitrogen atmosphere and maintained at 60℃ for 4 to 5 hours until complete reaction of the acid had taken place (as monitored using HPLC) . Thereafter, excess thionyl chloride was removed at 60 to 75℃ under reduced pressure. The resulting mixture was cooled to room temperature.
The cooled mixture was diluted with 500g of toulene and 200g of triethyl amine (TEA) with stirring. To this homogeneous mixture, 400g of 4’-chlorobiphenyl-2-amine was added over a period of 30 to 45 minutes at 45℃ and the mixture stirred for an additional 4 to 5 hours to allow the reaction to complete. The mixture was quenched by adding water and stirring for a further 2 to 3 hours.
The organic layer was separated and maintained at an elevated temperature of 60℃. The mixture was filtered to remove insoluble impurities. The mixture was finally cooled to 10 to 15℃ under slow stirring. The solid was isolated by filtration and drying to give 450 to 480g of boscalid.
The solid was analysed by IR spectroscopy, as in Example 1, which showed the solid product to be the crystalline modification II of the anhydrate of boscalid.
Example 3
A reaction vessel was charged with 792g (3.888 mol) of 2-amino-4'-chlorobiphenyl in 622g of xylene and the mixture was stirred until a homogenous solution was obtained. A solution of 698g (3.968 mol) of 2-chloro-3-nicotinyl chloride in 466g of xylene was added to the reaction vessel and the resultant mixture allowed to heat up to a temperature of 30℃.
The resultant mixture was heated to an elevated temperature of 95℃ over a period of 4 to 5 hours. Hydrogen chloride (HCl) produced by the reactions was removed using an external scrubber and absorption by a spray tower using water and an alkali solution. The reaction mixture was further maintained for a period of from 2 to 3 hours with stirring at the same elevated temperature to remove all traces of all HCl.
The resulting mixture was seeded with seed crystals of the crystalline modification II of the anhydrate of boscalid, resulting in the precipitation of a solid material, which was collected by filtration. Traces of xylene were removed from the precipitate by vacuum drying in an oven.
The solid material collected was analyzed using infrared (IR) spectrometry using a Bruker model No. Tensor 37 spectrometer, with a recording wavelength of 550 to 4000 cm-1, having 16 scans with a highest resolution of 4 cm-1. The analysis showed the solid product to be the crystalline modification II of the anhydrate of boscalid.
Example 4
375g of the carbonyl intermediate of chloronicotinic acid was prepared following the procedure described in Example 2 and reacted with 400g of 4’-chlorobiphenyl-2-amine to obtain a crude boscalid product. This product was repeatedly washed with tetrahydrofuran (THF) and diluted with 850g of isopropyl alcohol. The resulting solution was heated to 60℃and maintained at this temperature for 2 to 3 hours.
The resulting mixture was cooled to obtain a solid precipitate. The solid was isolated by filtration and drying.
The solid was analysed by IR spectroscopy, as in Example 1, which showed the solid product to be the crystalline modification II of the anhydrate of boscalid.
To investigate the effects of temperature on the solid boscalid material obtained in the process, the procedure of Example 1 was repeated with precipitating solid boscalid from  the xylene solution held at a range of different elevated temperatures before cooling.
The results are summarized in the following table.
Figure PCTCN2017094624-appb-000007
As can be seen from the results summarized in the above table, the form of the boscalid anhydrate precipitated from the organic solvent is dependent upon the temperature of the solution of boscalid from which the precipitation is carried out. In particular, precipitation from xylene heated to a temperature of 65℃ yielded 100%of the crystalline modification II of the anhydrate of boscalid. In contrast, precipitation from the xylenic solution heated to just 30℃ yielded only 10 to 20%of the crystalline modification II of the anhydrate of boscalid, with predominantly crystalline modification I of boscalid being formed at this temperature.

Claims (27)

  1. A process for preparing the crystalline modification II of the anhydrate of boscalid, the process comprising providing a solution of boscalid in an organic solvent system, heating the solution to an elevated temperature, and precipitating solid boscalid from the solution, the elevated temperature being sufficient to preferentially form the crystalline modification II of the anhydrate of boscalid.
  2. The process according to claim 1, wherein the solvent system comprises a polar organic solvent, an aromatic hydrocarbon, or a mixture thereof.
  3. The process according to claim 2, wherein the polar organic solvent is selected from an alcohol, a ketone, an ether, an ester, an amide, and mixtures thereof.
  4. The process according to claim 3, wherein the alcohol is a straight chain or branched aliphatic alcohol or an alicyclic alcohol.
  5. The process according to claim 4, wherein the alcohol is selected from ethanol, propanol, butanol, cyclohexanol, ethylene glycol and diethylene glycol.
  6. The process according to claim 3, wherein the ketone is a selected from propanone, butanone, pentanone and hexanone.
  7. The process according to claim 3, wherein the ether is selected from dioxane and tetrahydrofuran.
  8. The process according to claim 3, wherein the ester is selected from ethyl acetate and methyl acetate.
  9. The process according to claim 3, wherein the amide is dimethylformamide.
  10. The process according to claim 2, wherein the aromatic solvent is selected from benzene, toluene and xylene.
  11. The process according to any preceding claim, wherein the solvent system is substantially free of water.
  12. The process according to any preceding claim, wherein the solution is formed by dissolving a form of boscalid other than solid crystalline modification II of boscalid in the organic solvent system.
  13. The process according to any of claims 1 to 11, wherein the solution is formed by synthesizing boscalid in the presence of the organic solvent system.
  14. The process according to any preceding claim, wherein the elevated temperature is  below the boiling point of the solution.
  15. The process according to any preceding claim, wherein the elevated temperature is at least 45℃.
  16. The process according to claim 15, wherein the elevated temperature is at least 55℃.
  17. The process according to claim 16, wherein the elevated temperature is at least 65℃.
  18. The process according to any preceding claim, wherein the elevated temperature is below 100℃.
  19. The process according to claim 18, wherein the elevated temperature is below 85℃.
  20. The process according to claim 19, wherein the elevated temperature is from 55 to 85℃.
  21. The process according to any preceding claim, wherein precipitation of solid boscalid takes place at the elevated temperature.
  22. The process according to any preceding claim, wherein precipitation of solid boscalid takes place at a temperature below the elevated temperature.
  23. The process according to any preceding claim, wherein precipitation is aided by the addition of seed crystals to the solution.
  24. The process according to claim 23, wherein the seed crystals are crystals of the crystalline modification II of the anhydrate of boscalid.
  25. The process according to any preceding claim, wherein the process is conducted in a batchwise or a continuous manner.
  26. A process for preparing the crystalline modification II of the anhydrate of boscalid substantially as hereinbefore described.
  27. A fungicidal formulation comprising the crystalline modification II of the anhydrate of boscalid prepared by a process according to any preceding claim.
PCT/CN2017/094624 2016-08-04 2017-07-27 Process for preparing boscalid Ceased WO2018024145A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201780044954.4A CN109476603A (en) 2016-08-04 2017-07-27 Method for preparing boscalid

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1613462.9 2016-08-04
GB1613462.9A GB2552699B (en) 2016-08-04 2016-08-04 Process for preparing boscalid

Publications (1)

Publication Number Publication Date
WO2018024145A1 true WO2018024145A1 (en) 2018-02-08

Family

ID=60940414

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/094624 Ceased WO2018024145A1 (en) 2016-08-04 2017-07-27 Process for preparing boscalid

Country Status (4)

Country Link
CN (1) CN109476603A (en)
GB (1) GB2552699B (en)
TW (1) TWI733869B (en)
WO (1) WO2018024145A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023062649A1 (en) * 2021-10-14 2023-04-20 Natco Pharma Limited An improved process for the preparation of anhydrous crystalline form-i of boscalid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1558901A (en) * 2001-09-25 2004-12-29 �����ɷ� Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives
CN1575281A (en) * 2001-11-02 2005-02-02 巴斯福股份公司 Method for producing 2-halogen-pyridine-carboxylic acid amides
CN1751026A (en) * 2003-02-14 2006-03-22 巴斯夫股份有限公司 New crystal form of boscalid
CN103980192A (en) * 2014-01-20 2014-08-13 泰州百力化学股份有限公司 Selective synthesis method of cyprosulfamide with different crystal forms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103073489A (en) * 2013-02-06 2013-05-01 利民化工股份有限公司 Preparation method of Boscalid
CN105541709A (en) * 2016-02-25 2016-05-04 尚振华 Method for preparing boscalid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1558901A (en) * 2001-09-25 2004-12-29 �����ɷ� Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives
CN1575281A (en) * 2001-11-02 2005-02-02 巴斯福股份公司 Method for producing 2-halogen-pyridine-carboxylic acid amides
CN1751026A (en) * 2003-02-14 2006-03-22 巴斯夫股份有限公司 New crystal form of boscalid
CN103980192A (en) * 2014-01-20 2014-08-13 泰州百力化学股份有限公司 Selective synthesis method of cyprosulfamide with different crystal forms

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023062649A1 (en) * 2021-10-14 2023-04-20 Natco Pharma Limited An improved process for the preparation of anhydrous crystalline form-i of boscalid

Also Published As

Publication number Publication date
CN109476603A (en) 2019-03-15
TWI733869B (en) 2021-07-21
GB2552699A (en) 2018-02-07
GB2552699B (en) 2021-03-10
TW201808904A (en) 2018-03-16

Similar Documents

Publication Publication Date Title
AU2005289099B2 (en) Process for the preparation of 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide
TWI895304B (en) A preparing method of diethylamino hydroxybenzoyl hexylbenzoate
US7999106B2 (en) Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form I
KR101146446B1 (en) Novel crystalline modification of the anhydrate of boscalid
US10364225B2 (en) Process for preparing boscalid
WO2018024145A1 (en) Process for preparing boscalid
TWI756173B (en) Process for preparing boscalid
WO2019085681A1 (en) Process for the preparation of thiamethoxam
TWI750119B (en) Process for drying polymorph i of anhydrate of boscalid
WO2018024148A1 (en) Process for preparing boscalid
WO2018024146A1 (en) Process for preparation of boscalid
EP2657232A2 (en) Process for the purification of a benzenesulphonamide compound
AU2013368947A1 (en) Process for preparing amorphous Cabazitaxel
WO2013087800A1 (en) Plant growth regulating compounds
GB2564284A (en) Thiamethoxam and uses thereof
CN111116557A (en) Flazasulfuron crystal form and preparation method thereof
CN111004216A (en) Flazasulfuron crystal form and preparation method thereof
HK40003591B (en) Polymorphic forms of belinostat and processes for preparation thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17836327

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17836327

Country of ref document: EP

Kind code of ref document: A1